Unfortunately, estimates put the discontinuation rate of these medications as high as 50 percent in the first year
Trial design: mechanism-anchored endpoints Too many studies report ROS lowering without benefit
Results: GHK-Cu alleviated weight loss, improved the disease activity index (DAI), reduced colonic edema and shortening, attenuated inflammatory damage, increased goblet cell numbers, suppressed inflammatory cytokines such as TNF-, IL-6, and IL-1, and promoted mucosal repair
Clinical screening depth a proper intake screens for thyroid cancer and MEN-2 history, not just a checkbox
Intranasal fentanyl use in neonates
Side effects include nightmares, vivid dreams, next day grogginess, headache, irritability, upset tummy, dizziness, low blood pressure, bedwetting